Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids: Impact on Size and Vascularization.

NCT05604001 is registered in ClinicalTrials.gov with Ariel University as lead sponsor.

NCT NCT05604001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05604001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids: Impact on Size and Vascularization.
Lead sponsor
Ariel University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
December 30, 2019
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

laser hysteroscopic ablation of submucous myoma